Baguley BC - Search Results

1

Experimental antitumor activity of the amsacrine analogue CI-921.

Leopold WR 3rd, Corbett TH, Griswold DP Jr, Plowman J, Baguley BC. Leopold WR 3rd, et al. Among authors: baguley bc. J Natl Cancer Inst. 1987 Aug;79(2):343-9. J Natl Cancer Inst. 1987. PMID: 3474465

2

Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma.

Baguley BC, Finlay GJ. Baguley BC, et al. J Natl Cancer Inst. 1988 Apr 6;80(3):195-9. doi: 10.1093/jnci/80.3.195. J Natl Cancer Inst. 1988. PMID: 3346911

3

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).

Hardy JR, Harvey VJ, Paxton JW, Evans P, Smith S, Grove W, Grillo-Lopez AJ, Baguley BC. Hardy JR, et al. Among authors: baguley bc. Cancer Res. 1988 Nov 15;48(22):6593-6. Cancer Res. 1988. PMID: 3180070

4

Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.

Kestell P, Paxton JW, Evans PC, Young D, Jurlina JL, Robertson IG, Baguley BC. Kestell P, et al. Among authors: baguley bc. Cancer Res. 1990 Feb 1;50(3):503-8. Cancer Res. 1990. PMID: 2297692

5

Multiple patterns of resistance of human leukemia cell sublines to amsacrine analogues.

Finlay GJ, Baguley BC, Snow K, Judd W. Finlay GJ, et al. Among authors: baguley bc. J Natl Cancer Inst. 1990 Apr 18;82(8):662-7. doi: 10.1093/jnci/82.8.662. J Natl Cancer Inst. 1990. PMID: 2157028

6

Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.

Baguley BC, Denny WA, Atwell GJ, Finlay GJ, Rewcastle GW, Twigden SJ, Wilson WR. Baguley BC, et al. Cancer Res. 1984 Aug;44(8):3245-51. Cancer Res. 1984. PMID: 6547635

7

Effects of CI-921, an analogue of amsacrine, on advanced Lewis lung tumours in mice: relevance to clinical trials.

Baguley BC, Calveley SB, Harvey VJ. Baguley BC, et al. Eur J Cancer Clin Oncol. 1988 Feb;24(2):211-8. doi: 10.1016/0277-5379(88)90255-6. Eur J Cancer Clin Oncol. 1988. PMID: 3356209

8

Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin.

Finlay GJ, Ching LM, Wilson WR, Baguley BC. Finlay GJ, et al. Among authors: baguley bc. J Natl Cancer Inst. 1987 Aug;79(2):291-6. J Natl Cancer Inst. 1987. PMID: 3474463

9

Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance.

Baguley BC, Holdaway KM, Fray LM. Baguley BC, et al. J Natl Cancer Inst. 1990 Mar 7;82(5):398-402. doi: 10.1093/jnci/82.5.398. J Natl Cancer Inst. 1990. PMID: 2154584

10

Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.

Atwell GJ, Rewcastle GW, Baguley BC, Denny WA. Atwell GJ, et al. Among authors: baguley bc. J Med Chem. 1987 Apr;30(4):652-8. doi: 10.1021/jm00387a012. J Med Chem. 1987. PMID: 3560159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters